Genevax vaccine (Apollon)

N/A

Report date: 2023/05/05 17:09:13

Base Information

Drug NameGenevax vaccine (Apollon)
Drug Alias NameGenevax vaccine (lymphoma)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLymphoma, T-Cell, PeripheralLymphoma, T-Cell, CutaneousLymphoma, T-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesApollon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApollonWyeth Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsLymphoma, T-Cell, PeripheralLymphoma, T-Cell, CutaneousLymphoma, T-Cell

Other Information

ATC CodeN/A
Related LinksN/A